French Aerospace & Defense Stock News

Lagardere (ENXTPA:MMB) is back in focus after releasing its full year 2025 results. The company reported higher sales, revenue, and earnings per share, along with a record adjusted EBIT and lower net debt. See our latest analysis for Lagardere. The earnings release comes after a period where short term share price momentum has been modest, with a 7 day share price return of 3.82% and a 1 year total shareholder return decline of 8.36%, hinting that the market is still weighing improved...

Context for Euronext’s Recent Share Performance Euronext (ENXTPA:ENX) has drawn fresh attention after recent share price moves, with the stock up 4.8% over the past month but showing a 1.1% decline over the past 3 months. See our latest analysis for Euronext. Looking beyond the recent bounce, Euronext’s share price return over the past year has been more muted than its very large 3 year total shareholder return of about 7x. This suggests that earlier momentum has cooled even as investors who...

Why Nexans is on investors’ radar today Nexans (ENXTPA:NEX) has attracted fresh attention after recent share price moves, with the stock showing mixed short term performance and stronger multi year total returns that may prompt investors to reassess the cable maker’s profile. See our latest analysis for Nexans. Recent trading has been choppy, with a 7 day share price return of an 8.36% decline and a relatively flat 30 day share price return of a 0.39% decline. However, the 1 year total...

Sartorius Stedim Biotech (ENXTPA:DIM) just released its full year 2025 results, reporting sales of €2,967.5m and net income of €265.6m, putting fresh financial data in focus for shareholders. See our latest analysis for Sartorius Stedim Biotech. The latest full year results land at a time when momentum has been mixed, with a 3.86% 1 day share price return and 4.46% 7 day share price return, compared with a 1 year total shareholder return of 10.25% and a 42.86% 3 year total shareholder return...

Schneider Electric (ENXTPA:SU) has introduced EcoStruxure Foxboro Software Defined Automation, an open, software-defined distributed control system designed to tackle aging infrastructure, high operating costs, and modernization needs in hybrid and process industries. See our latest analysis for Schneider Electric. The EcoStruxure Foxboro SDA launch lands at a time when Schneider Electric’s 1 month share price return of 13.65% and 90 day share price return of 17.81% suggest firming momentum...

Wondering if EssilorLuxottica Société anonyme is fairly priced at its current level, or if the market is missing something about its long term potential. The share price closed at €238.20, with returns of 7.8% decline over the past week, 11.1% decline over the past month, and 10.3% decline year to date, while the 1 year return is 16.8% decline, compared with gains of 52.5% over 3 years and 90.7% over 5 years. These mixed return figures suggest that sentiment around the stock has shifted over...

If you are wondering whether Sanofi shares are offering fair value at around €79.58, you are not alone. This article is built to help you weigh what the current price might be saying. Over the past week the stock is up 2.5%, while the 1 year return sits at a 20.2% decline and the year to date return is a 3.3% decline, with a relatively flat 3 year return of 0.2% and a 5 year return of 27.9%. Recent headlines around Sanofi have focused on the broader healthcare and pharmaceuticals space,...

Abivax (ENXTPA:ABVX) presented new preclinical and clinical data for obefazimod at the ECCO Congress. The data highlighted anti fibrotic activity in Crohn's disease and rapid symptomatic relief in inflammatory bowel disease. Large Phase 3 trials were reported to show a strong safety profile and further validation of obefazimod's miR 124 targeting mechanism. Abivax focuses on inflammatory and autoimmune diseases, with obefazimod positioned as its lead asset in inflammatory bowel disease. For...

L'Air Liquide (ENXTPA:AI) drew attention after reporting full year 2025 results, with net income of €3,517.9m on sales of €26,940.2m, alongside a proposed 12.1% higher dividend of €3.70. See our latest analysis for L'Air Liquide. The proposed 12.1% dividend increase and solid full year 2025 net income appear to have fed into recent optimism, with a 1 month share price return of 11.68% at €175.56 and a 5 year total shareholder return of 86.58%. This suggests that momentum has been building...

Tikehau Capital (ENXTPA:TKO) has drawn fresh attention after reporting full year 2025 earnings, with net income of €136.4 million, a proposed €0.80 dividend per share, completed buybacks, and upcoming board changes. See our latest analysis for Tikehau Capital. The strong 1 day share price return of 6.88% to €17.10, alongside a 15.54% 3 month share price return, contrasts with a 1 year total shareholder return of 18.11% decline. This suggests recent momentum has not yet reversed longer term...

Why FDJ United’s latest moves matter for shareholders FDJ United (ENXTPA:FDJU) is back in focus after a packed update, combining full year 2025 results, a proposed dividend increase, fresh 2026 guidance and senior leadership changes on the executive committee. For you as an investor, this mix of operational data, payout policy and management reshuffle helps frame how the business is being run and how shareholder returns are being approached over the coming year. See our latest analysis for...

Without a clear single news catalyst, Danone (ENXTPA:BN) tends to draw attention from investors through its recent share performance, dividend profile, and how its current valuation compares with its underlying fundamentals. See our latest analysis for Danone. At a share price of €73.6, Danone has recently seen a 7.82% 1 month share price return, while its year to date share price return is a 3.21% decline. The 1 year total shareholder return of 10.57% and 3 year total shareholder return of...

Kering (ENXTPA:KER) is back in focus after reporting full year 2025 results that showed sales of €14,675m and net income of €72m, sharply below the prior year’s figures. See our latest analysis for Kering. The weak 2025 earnings, the proposed lower ordinary dividend of €3.00 per share and the leadership change at Bottega Veneta have come against a backdrop of a 6.14% 90 day share price decline and a 44.92% 3 year total shareholder return loss. This signals pressure rather than momentum,...

Solocal Group (ENXTPA:LOCAL) has just posted its FY 2025 numbers, with second half revenue of €160.4 million and net income of €8.8 million, while the trailing twelve months show revenue of €324.5 million and net income of €14.2 million anchoring the earnings picture. The business has seen half year revenue move from €170.7 million in the second half of 2024 to €164.1 million in the first half of 2025 and then to €160.4 million in the latest period, alongside EPS of €5.47, €5.07 and €0.16...

DBV Technologies (ENXTPA:DBV) is back in focus as it prepares to share fresh VITESSE Phase 3 data on its VIASKIN Peanut Patch at the 2026 AAAAI Annual Meeting, spotlighting peanut allergy treatment in young children. See our latest analysis for DBV Technologies. Those upcoming VITESSE Phase 3 readouts and recent conference appearances come after a sharp shift in sentiment, with the share price at €3.56, a 90 day share price return of 48.95% and a 1 year total shareholder return above 300%,...

Why Icade’s latest earnings matter for shareholders Icade (ENXTPA:ICAD) has just wrapped up its 2025 financial year. The board met on 17 February 2026 to approve results that featured lower revenue but a smaller net loss. The group reported 2025 revenue of €1,449.6 million and sales of €346.5 million, both below the previous year. The net loss narrowed to €123 million, alongside a reduced loss per share from continuing operations. See our latest analysis for Icade. At a share price of €21.2,...

If you are wondering whether Nexans is still reasonably priced after its recent run, or if the value story has started to cool, this article is for you. The share price closed at €126.60, with a 9.8% decline over the past week, a 2.2% gain over the last 30 days, and returns of 21.4% over 1 year, 47.9% over 3 years, and 123.2% over 5 years. These moves have put valuation back in focus, especially for investors comparing the recent short term pullback with the stronger multi year returns. With...

Vallourec (ENXTPA:VK) is back in focus after announcing a collaboration with Baker Hughes to combine its Delphy underground hydrogen storage solution with Baker Hughes compression technology for green hydrogen projects. See our latest analysis for Vallourec. The Baker Hughes agreement comes after a period of strong share price momentum for Vallourec, with a 30 day share price return of 17.18% and a year to date share price return of 22.53%, while the 3 year total shareholder return of 56.59%...

Sanofi (ENXTPA:SAN) has wrapped up FY 2025 with fourth quarter revenue of €12.2b and a basic EPS loss of €0.67, alongside trailing 12 month revenue of €46.7b and EPS of €4.05 that still reflect the impact of a large one off €3.4b charge. Over recent periods, revenue has moved between €10.6b and €14.2b a quarter, while basic EPS has ranged from €1.01 to €2.32 in the first three quarters of 2025 before this latest loss. This sets a mixed backdrop for the trailing 10.6% net margin versus 12.4% a...

Verallia Société Anonyme is reviewing its European operations, including potential site closures and job cuts, as part of its sustainability and investment plans. The review focuses on facilities in Germany, France, and the UK, where the company is responding to weaker demand for glass packaging. These possible changes could affect employees and production capacity across key European markets. For investors watching ENXTPA:VRLA, this operational review comes after a period of weaker share...

Why the COP17 Mongolia contract matters for GL Events GL Events (ENXTPA:GLO) has been chosen by the Municipality of Ulaanbaatar to supply around 44,500 sqm of temporary infrastructure for COP17, which is expected to host nearly 10,000 delegates in Mongolia. See our latest analysis for GL Events. The COP17 announcement lands at a time when momentum in GL Events’ shares already appears firm, with a 30-day share price return of 18.36% and a 1-year total shareholder return of 81.18% supporting a...

Dividend and buyback plans put Carmila in focus Carmila (ENXTPA:CARM) has drawn fresh attention after reporting profitable growth in 2025, proposing a 9% higher dividend of €1.36 per share, and launching a €10 million share buyback program. See our latest analysis for Carmila. Carmila's latest dividend and buyback announcements come after a steady build in momentum, with a 30 day share price return of 8.52% and a 1 year total shareholder return of 7.29%. The 3 year total shareholder return of...

Euronext plans to propose a higher dividend for 2025 at its upcoming AGM, in line with its stated dividend policy. The proposed dividend represents nearly a 10% increase compared with the prior year. Euronext (ENXTPA:ENX), trading at around €126.5, is coming off a strong medium term run, with the share price up 92.9% over 3 years and 73.4% over 5 years. In the shorter term, the stock is up 5.0% over the past week and 3.3% over the past month, while the year to date gain sits at 0.7%. For...

bioMérieux (ENXTPA:BIM) has drawn fresh attention with the launch of SMARTBIOME, a new solution that uses DNA sequencing and bioinformatics to help food manufacturers tackle microbiological spoilage and cut waste. See our latest analysis for bioMérieux. Despite the SMARTBIOME launch drawing attention to bioMérieux’s food safety offering, the share price at €94.2 follows a 30‑day share price return of a 9.8% decline and a year‑to‑date share price return of a 14% decline, while the 1‑year total...